Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021)
Aurinia Pharmaceuticals (AUPH) posted Amortization - Intangibles of $524000.0 for Q4 2021, up 4.8% on a QoQ basis from $500000.0 in Q3 2021, and up 31.0% year-over-year from $400000.0 in Q4 2020.
Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021) Analysis & Trends
Aurinia Pharmaceuticals' Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $524000.0 for Q4 2021.
- Quarterly Amortization - Intangibles rose 31.0% year-over-year to $524000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2.0 million (up 55.55% YoY) and the FY2021 annual result came in at $2.1 million, up 61.54% from the prior year.
- Amortization - Intangibles was $524000.0 for Q4 2021 at Aurinia Pharmaceuticals, up from $500000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $524000.0 in Q4 2021 and bottomed at $300000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 524,000.00 |
| Sep 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 523,000.00 |
| Dec 31, 2020 | 400,000.00 |
| Sep 30, 2020 | 316,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 300,000.00 |